Seven Novel Therapies Driving Progress in Spinal Muscular Atrophy
The Spinal Muscular Atrophy (SMA) therapeutic arena has transitioned from a niche space with limited intervention to a high-value, dynamic market characterized by rapid innovation and significant commercial potential
